G01N 2333/503
Basic fgf [bfgf]
Official title: basic FGF [bFGF]
G01N2333/503 (Basic fgf [bfgf]) appears on 89 US grants and 35 published applications in this corpus.
Search patents in G01N- Granted patents
- 89
- Published applications
- 35
- Assignees
- 30
- Inventors
- 92
- Latest grant
- 5 Jan 2021
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 1995 | 4 | 0 |
| 1996 | 6 | 0 |
| 1997 | 18 | 0 |
| 1998 | 25 | 0 |
| 1999 | 4 | 0 |
| 2000 | 4 | 0 |
| 2001 | 6 | 0 |
| 2002 | 2 | 4 |
| 2003 | 1 | 7 |
| 2004 | 5 | 4 |
| 2005 | 3 | 2 |
| 2006 | 2 | 2 |
| 2007 | 1 | 1 |
| 2008 | 1 | 1 |
| 2009 | 0 | 2 |
| 2010 | 0 | 1 |
| 2011 | 0 | 0 |
| 2012 | 1 | 1 |
| 2013 | 0 | 0 |
| 2014 | 0 | 0 |
| 2015 | 0 | 3 |
| 2016 | 0 | 1 |
| 2017 | 2 | 1 |
| 2018 | 1 | 1 |
| 2019 | 1 | 1 |
| 2020 | 1 | 1 |
| 2021 | 1 | 0 |
| 2022 | 0 | 0 |
| 2023 | 0 | 0 |
| 2024 | 0 | 0 |
| 2025 | 0 | 0 |
| 2026 | 0 | 2 |
By publication year. Applications have been published since 2001. 2026 runs to 8 Oct.
Recent patents
- Monoclonal antibodies to human fibroblast growth factor receptor 2 (HFGFR2) and methods of use thereof5 Jan 2021US 10,881,734 B2Daiichi Sankyo Company, Limited
- Method of synthesizing antagonist peptides for cell growth18 Aug 2020US 10,745,454 B2
- Monoclonal antibodies to human fibroblast growth factor receptor 2 (HFGFR2) and methods of use thereof19 Nov 2019US 10,478,496 B2Daiichi Sankyo Company, Limited
- Use of substances to protect FGF-2 or FGF-beta growth factor27 Mar 2018US 9,925,134 B2BASF Beauty Care Solutions France S.A.S.
- Methods of treating mesothelioma by administration of compounds comprising FGFR1 ECD3 Oct 2017US 9,775,881 B2Five Prime Therapeutics, Inc.
- Human anti-fgf2 monoclonal antibody (mab), pharmaceutical composition comprising same, use thereof and kit for the detection of cancer in a biological sample comprising said mab1 Oct 2026US 2026/0297170 A1Instituto Butantan
- Combination drug21 May 2026US 2026/0140118 A1Chugai Seiyaku Kabushiki Kaisha
- Monoclonal antibodies to human fibroblast growth factor receptor 2 (hfgfr2) and methods of use thereof19 Mar 2020US 2020/0085946 A1Daiichi Sankyo Company, Limited
- Method of synthesizing antagonist peptides for cell growth1 Aug 2019US 2019/0233490 A1
- Detection of fgfr217 May 2018US 2018/0133314 A1Daiichi Sankyo Company, Limited
Most cited
By later US patents
- Nucleic acid ligands561US 5,475,096 AUniversity Research Corporation · 1995
- Systematic evolution of ligands by exponential enrichment: chimeric selex281US 5,637,459 ANeXstar Pharmaceuticals, Inc. · 1997
- High affinity nucleic acid ligands containing modified nucleotides228US 5,660,985 ANeXstar Pharmaceuticals, Inc. · 1997
- Methods of producing nucleic acid ligands204US 5,595,877 ANeXstar Pharmaceuticals, Inc. · 1997
- High affinity nucleic acid ligands containing modified nucleotides190US 5,958,691 ANeXstar Pharmaceuticals, Inc. · 1999